Clinical Evaluation of Cancer Signal Origin (CSO) Prediction and Diagnostic Resolution Following Multi-Cancer Early Detection Testing Grail Content Editor Clinical Evaluation of Cancer Signal Origin (CSO) Prediction and Diagnostic Resolution Following Multi-Cancer Early Detection Testing Read More »
Preclinical Circulating Tumor DNA (ctDNA) Shedding Duration and Prognostic Implications of Modeling 3669 Participants From American Cancer Society Cancer Prevention Study-3 (CPS-3) and Circulating Cell-Free Genome Atlas Substudy 3 (CCGA3) Grail Content Editor Preclinical Circulating Tumor DNA (ctDNA) Shedding Duration and Prognostic Implications of Modeling 3669 Participants From American Cancer Society Cancer Prevention Study-3 (CPS-3) and Circulating Cell-Free Genome Atlas Substudy 3 (CCGA3) Read More »
Early Real-World Experience With a Multi-Cancer Early Detection Test Grail Content Editor Early Real-World Experience With a Multi-Cancer Early Detection Test Read More »
Large-scale observational prospective cohort study of a multi-cancer early detection (MCED) test in symptomatic patients referred for cancer investigation Grail Content Editor Large-scale observational prospective cohort study of a multi-cancer early detection (MCED) test in symptomatic patients referred for cancer investigation Read More »
NHS-Galleri Trial Design: Equitable study recruitment tactics for targeted population-level screening with a multi-cancer early detection (MCED) test Grail Content Editor NHS-Galleri Trial Design: Equitable study recruitment tactics for targeted population-level screening with a multi-cancer early detection (MCED) test Read More »
A Prespecified Interim Analysis of the PATHFINDER Study: Performance of a Multi‐Cancer Early Detection Test in Support of Clinical Implementation Grail Content Editor A Prespecified Interim Analysis of the PATHFINDER Study: Performance of a Multi‐Cancer Early Detection Test in Support of Clinical Implementation Read More »
Interim Results of PATHFINDER, a Clinical Use Study Using a Methylation-Based Multi-Cancer Early Detection Test Grail Content Editor Interim Results of PATHFINDER, a Clinical Use Study Using a Methylation-Based Multi-Cancer Early Detection Test Read More »
Reductions in Cancer Screening: The Consequence of Changes in Routine care During the COVID-19 Pandemic Grail Content Editor Reductions in Cancer Screening: The Consequence of Changes in Routine care During the COVID-19 Pandemic Read More »
Performance of a Targeted Methylation-Based Multi-Cancer Early Detection Test by Race/Ethnicity\” Grail Content Editor Performance of a Targeted Methylation-Based Multi-Cancer Early Detection Test by Race/Ethnicity\” Read More »
Performance of a Targeted Methylation-Based Multi-Cancer Early Detection Test by Race/Ethnicity\” Grail Content Editor Performance of a Targeted Methylation-Based Multi-Cancer Early Detection Test by Race/Ethnicity\” Read More »
